Clear 29°. Wind Chill: 25°. Wind: SW 5 mph.
Trending: Muslim rights group sues Florida Gov. DeSantis over ‘foreign terrorist’ label
HomeNewsNationalHealth ( Page 117)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Pricing group says weight-loss drugs becoming more cost-effective

By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as their prices have fallen and studies have shown proof of their cardiovascular health benefits. In a draft report, the Institute for Clinical and Economic ...
by

UnitedHealth expects top-rated Medicare plans membership in line with expectations

(Reuters) -UnitedHealth said on Tuesday it expects enrollment in top-rated Medicare insurance plans to be in line with its expectations. Though the data for 2026 star ratings, given by the Centers for Medicare and Medicaid Services (CMS), is not in yet, the company expects ...
by

Norway reports bird flu outbreak on farm, international agency says

PARIS (Reuters) – Norway has reported an outbreak of highly pathogenic H5N1 avian influenza, or bird flu, on a farm in the north of the country, the World Organisation for Animal Health (WOAH) said on Tuesday, as Europe faces a ...
by

Exclusive-Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

By Svea Herbst-Bayliss NEW YORK (Reuters) -Altai Capital Management is preparing to launch a board fight at OraSure Technologies after the hedge fund, already one of the biggest owners of the medical device maker, increased its holdings, two people familiar with the matter told Reuters. The ...
by

Novartis to acquire Tourmaline Bio for $1.4 billion

BERLIN (Reuters) – Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a ...
by

Previous CT scans may increase pregnancy risks

By Nancy Lapid (Reuters) -Women who have undergone computed tomography imaging may be at slightly higher risk for pregnancy loss and birth defects in later pregnancies, according to findings from a large Canadian study. The increase in risk is small and dependent on the number ...
https://www.osfhealthcare.org/c/only-at-osf-w
by

Spaceflight accelerates the aging of human blood-forming stem cells

By Will Dunham WASHINGTON (Reuters) -New research has identified yet another way that spaceflight tampers with the human body. A study involving samples flown on four SpaceX resupply missions to the International Space Station has revealed that space travel accelerates the aging of blood-forming stem ...
by

WATCH: DHS launches ICE ‘Midway Blitz’ in Chicago as Trump calls out cashless bail

(The Center Square) – As the U.S. Department of Homeland Security announces a new operation in Chicago, President Donald Trump says he is not going to war with the city. ...
by

Balzan prizes of nearly $1 million awarded for democracy studies and advances in leukemia treatment

MILAN (AP) — American historian Josiah Ober, whose studies of Athenian democracy provide insights into current political crises, and U.S. immunologist Carl H. June, who works on gene-modified cell therapy that offers hope for future cures of autoimmune diseases, were among four winners of ...
by

Op-Ed: Illinois just cemented its place as a ‘Legislative Inferno’

Illinois already has a reputation for having one of the most hostile civil legal climates in America. On August 15, 2025, Governor JB Pritzker signed Senate Bill 328 into law and, with a single signature, took our business climate from bad to worse. The ...
by

BioNTech, Bristol Myers’ immunotherapy shows encouraging tumour shrinkage in Phase II trial

FRANKFURT (Reuters) -A next-generation cancer immunotherapy by BioNTech and partner Bristol Myers Squibb led to encouraging tumour shrinkage in a mid-stage trial on small cell lung cancer that has started spreading, the German biotech firm said on Monday. A Phase II trial showed that 76.3% ...
by

LB Pharmaceuticals eyes $322 million valuation in biotech IPO amid sector drought

(Reuters) -Cash-strapped drug developer LB Pharmaceuticals said on Monday it was aiming for a valuation of up to $321.6 million in its New York initial public offering, potentially setting up the first sizable U.S. biotech flotation in months. WHY IT’S IMPORTANT   Biotech listings — historically ...
First Previous113114115116117118119120121Next Last